Related Experiment Video
Updated: Mar 19, 2026

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
Combating chronic bacterial infections by manipulating cyclic nucleotide-regulated biofilm formation
1Division of Molecular Microbiology, School of Life Science, University of Dundee, Dundee, UK.
Abstract:
Many pathogenic bacteria can form biofilms in clinical settings with major consequences for the progression of infections. Bacterial biofilm communities are typically much more resistant to both antibiotic treatment and clearance by the immune system in comparison to free-living cells. Therefore, drugs that specifically target the formation or maintenance of biofilms would be very valuable additions to current clinical options. Cyclic nucleotide second messengers, in particular cyclic-diguanosine-GMP (c-di-GMP), are now known to play a major role in biofilm formation, and maintenance, in many bacterial species. In this special report, we will review recent progress toward the development of drugs that interfere with c-di-GMP signaling as a route to control biofilm infections. We will focus on the chronic infections associated with the notorious opportunistic pathogen Pseudomonas aeruginosa, although the principles outlined here are also relevant to most bacterial pathogens.
Insights
New drugs targeting cyclic-diguanosine-GMP (c-di-GMP) signaling show promise for controlling bacterial biofilm infections, offering a novel approach against antibiotic-resistant pathogens like Pseudomonas aeruginosa.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Pathogenic bacteria form biofilms in clinical settings, leading to persistent infections.
- Biofilms exhibit increased resistance to antibiotics and host immune responses compared to planktonic cells.
- Targeting biofilm formation is crucial for developing effective anti-infective strategies.
Purpose of the Study:
- To review recent advancements in developing drugs that target cyclic-diguanosine-GMP (c-di-GMP) signaling pathways.
- To explore the potential of c-di-GMP interference as a therapeutic strategy against bacterial biofilms.
- To highlight the relevance of these strategies for controlling chronic infections, particularly those caused by Pseudomonas aeruginosa.
Main Methods:
- Review of current literature on c-di-GMP signaling in bacterial biofilms.
- Analysis of drug development efforts targeting c-di-GMP pathways.
- Focus on Pseudomonas aeruginosa as a model pathogen for biofilm control.
Main Results:
- Cyclic nucleotide second messengers, especially c-di-GMP, are critical regulators of biofilm formation and maintenance in many bacteria.
- Emerging drug candidates aim to disrupt c-di-GMP signaling to inhibit biofilm development.
- These approaches offer a potential alternative to conventional antibiotics for treating biofilm-associated infections.
Conclusions:
- Interfering with c-di-GMP signaling represents a promising therapeutic avenue for combating bacterial biofilm infections.
- Drug development targeting c-di-GMP pathways could provide valuable new options for clinical settings.
- The principles discussed are broadly applicable to various bacterial pathogens, with a specific focus on Pseudomonas aeruginosa chronic infections.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial Signaling

